Merck & Co., Inc. ( NYSE:MRK – Get Free Report ) has been given a consensus rating of 'Moderate Buy' by the nineteen analysts that are covering the company, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $124.74. MRK has been the topic of a number of research reports. BMO Capital Markets boosted their price objective on Merck & Co.

https://www.dailypolitical.com/2023/09/09/merck-co-inc-nysemrk-receives-124-74-consensus-target-price-from-brokerages.html

#dailypolitical